MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,220,756 | +32.5% | 1,620,910 | +8.5% | 0.00% | +50.0% |
| Q2 2023 | $38,660,568 | +37.5% | 1,494,417 | +27.7% | 0.00% | 0.0% |
| Q1 2023 | $28,113,609 | -59.0% | 1,170,425 | -66.7% | 0.00% | 0.0% |
| Q4 2022 | $68,586,102 | +230.1% | 3,517,236 | +255.6% | 0.00% | +100.0% |
| Q3 2022 | $20,778,000 | +287.1% | 988,962 | +258.5% | 0.00% | – |
| Q2 2022 | $5,368,000 | +83.6% | 275,867 | +107.8% | 0.00% | – |
| Q1 2022 | $2,923,000 | +48.1% | 132,744 | +7.3% | 0.00% | – |
| Q4 2021 | $1,974,000 | -22.0% | 123,735 | -2.6% | 0.00% | – |
| Q3 2021 | $2,532,000 | +16.4% | 127,089 | +1.0% | 0.00% | – |
| Q2 2021 | $2,175,000 | +21.1% | 125,786 | +38.8% | 0.00% | – |
| Q1 2021 | $1,796,000 | +8.3% | 90,618 | -4.6% | 0.00% | – |
| Q4 2020 | $1,659,000 | -16.3% | 95,018 | -7.6% | 0.00% | – |
| Q3 2020 | $1,981,000 | +6.4% | 102,803 | +7.5% | 0.00% | – |
| Q2 2020 | $1,861,000 | +164.7% | 95,655 | +90.4% | 0.00% | – |
| Q1 2020 | $703,000 | +25.5% | 50,228 | +120.1% | 0.00% | – |
| Q4 2019 | $560,000 | +184.3% | 22,819 | +16.3% | 0.00% | – |
| Q3 2019 | $197,000 | – | 19,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |